Landmark Bio Revenue and Competitors
Estimated Revenue & Valuation
- Landmark Bio's estimated annual revenue is currently $13.5M per year.
- Landmark Bio's estimated revenue per employee is $155,000
Employee Data
- Landmark Bio has 87 Employees.
- Landmark Bio grew their employee count by 43% last year.
Landmark Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Quality and Regulatory Officer | Reveal Email/Phone |
3 | Chief Technology Officer | Reveal Email/Phone |
4 | Associate VP For Analytical and Process Development | Reveal Email/Phone |
5 | AVP - Business Development | Reveal Email/Phone |
6 | VP, Cell & Gene Therapy, Product Development & Operation | Reveal Email/Phone |
7 | AVP - Digital Technolgies & Innovation | Reveal Email/Phone |
8 | VP, Business Operations | Reveal Email/Phone |
9 | VP, Watertown Site Head Technical Operations | Reveal Email/Phone |
10 | Associate Director - Digital Platforms | Reveal Email/Phone |
Landmark Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Landmark Bio?
Formerly known as the new center for advanced biological innovation and manufacturing (or “CABIM”), Landmark Bio, PBLLC is a public benefit limited liability company that was formed to advance the development of transformative new medicines by translating today’s cutting-edge research into tomorrow’s breakthrough therapies. The cross-sector partnership harnesses world-leading expertise to accelerate fast-emerging and promising science, the challenges of which are daunting for any single institution to tackle alone. Board members include leaders from Harvard University, Massachusetts Institute of Technology (MIT), FUJIFILM Diosynth Biotechnologies (FDB), Cytiva, and Alexandria Real Estate Equities, Inc. Other collaborating institutions include Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, the Dana-Farber Cancer Institute, Massachusetts General Hospital, and the Massachusetts Life Sciences Center. For more information please contact media@landmarkbio.com
keywords:N/A
N/A
Total Funding
87
Number of Employees
$13.5M
Revenue (est)
43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Greater Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $19.1M | 132 | 55% | $39M |
#2 | $20.9M | 158 | -9% | N/A |
#3 | $7.5M | 928 | 19% | N/A |
#4 | $596M | 1206 | 19% | N/A |